[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2009/318408,2009,A1Locationinpatent:Page/Pagecolumn90-91
[1]CurrentPatentAssignee:BAYERAG-US2017/260140,2017,A1Locationinpatent:Paragraph0715;0716;0717;0718
1162676-00-7
1184204-30-5
1227269-02-4
140373-77-9
1415920-00-1
157665-53-7
884860-63-3 | 2-Chlorothiazolo[4,5-c]pyridine | AA0049XT | MFCD13193436
887763-94-2 | 3-(4-Fluorophenyl)-1,2,4-oxadiazole | AA004AZN | MFCD16618955
88547-24-4 | Ac-4,5-dehydro-leu-oh | AA004CNN | MFCD00237465
887405-27-8 | N-Methyl-1-(5-methyl-1,3,4-oxadiazol-2-yl)methanamine | AA004DZ0 | MFCD09055379
874908-12-0 | Benzoic acid,4-[2-[[1-[2-[(4-carboxybutyl)amino]phenyl]-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxy- | AA004FI1 | MFCD12031413
880361-72-8 | N-Methyl-1-(3-methylpyridin-2-yl)methanamine | AA004GD6 | MFCD05864507
874630-03-2 | 2-((5-(Trifluoromethyl)pyridin-2-yl)amino)ethanol | AA004HE2 | MFCD07359872
863578-36-3 | 2-Amino-4-methylphenylboronic acid, pinacol ester | AA004IRO | MFCD06795679
884494-87-5 | 3-Bromo-5-chloro-2-fluoropyridine | AA004JGT | MFCD04972409
871332-88-6 | 3-(N-Propylaminocarbonyl)-5-nitrophenylboronic acid | AA004KJF | MFCD07783880